Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder
1
x
$
30.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
1
x
$
30.00
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
1
x
$
30.00
Wender Utah Rating Scale (WURS)
1
x
$
0.00
Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
1
x
$
30.00
Enfoque clínico: Componentes cognitivos y biológicos que participan en el desarrollo del trastorno por estrés postraumático
1
x
$
0.00
Schizophrenia and Valproate
1
x
$
30.00
View Cart
Checkout
Home
divalproex-sodium
“Schizophrenia and Valproate” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
$
30.00
Add to cart
Details
The Efficacy of Divalproex for Partial Epilepsies
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
The Use of Divalproex in the Treatment of Addictive Disorders
$
30.00
Add to cart
Details
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
Valproate Use in Neuropsychiatric Disorders in the Elderly
$
30.00
Add to cart
Details
Page load link
Go to Top
